NCT00483457View on ClinicalTrials.gov

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Solid Tumor
Interventions
DRUG

enzyme inhibitor therapy

enzyme inhibitor therapy

GENETIC

protein expression analysis

protein expression analysis

OTHER

immunohistochemistry staining method

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

laboratory biomarker analysis

PROCEDURE

biopsy

biopsy

Trial Locations (1)

37232

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER

NCT00483457 - Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients | Biotech Hunter | Biotech Hunter